Thus, it would be interesting to evaluate the contribution of other PIAS1 SUMO substrates in its potential ability to regulate breast cancer invasiveness and metastasis, and to its utility as a biomarker in breast cancer. This evidence concerns the gene PIAS1 and breast carcinoma.